Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis

  • Isrid Sturm1,
  • Andrew G Bosanquet3,
  • Michael Hummel4,
  • Bernd Dörken1, 2 and
  • Peter T Daniel1, 2Email author
BMC Cancer20055:105

https://doi.org/10.1186/1471-2407-5-105

Received: 06 May 2005

Accepted: 18 August 2005

Published: 18 August 2005

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 May 2005 Submitted Original manuscript
17 May 2005 Reviewed Reviewer Report - Eric Solary
18 Jun 2005 Reviewed Reviewer Report - Massimiliano Bonafé
8 Jul 2005 Author responded Author comments - Peter Daniel
Resubmission - Version 2
8 Jul 2005 Submitted Manuscript version 2
15 Jul 2005 Reviewed Reviewer Report - Massimiliano Bonafé
11 Aug 2005 Reviewed Reviewer Report - Eric Solary
17 Aug 2005 Author responded Author comments - Peter Daniel
Resubmission - Version 3
17 Aug 2005 Submitted Manuscript version 3
Publishing
18 Aug 2005 Editorially accepted
18 Aug 2005 Article published 10.1186/1471-2407-5-105

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Berlin-Buch and Department of Hematology and Oncology, University Medical Center Charité, Campus Virchow Klinikum, Humboldt University
(2)
Clinical and Molecular Oncology, Max Delbrück Center for Molecular Medicine
(3)
Bath Cancer Research, Royal United Hospital
(4)
Institute of Pathology, University Medical Center Charité, Campus Benjamin Franklin, Humboldt University

Advertisement